WuXi XDC provides single-source discovery, development, and manufacturing services for antibody-drug conjugates (ADCs) and other novel bioconjugates. These comprehensive, integrated CRDMO services include the key intermediates, such as the chemical payload-linkers and the biologics (e.g., monoclonal, bispecific and multispecific antibodies or other recombinant proteins), in addition to the bioconjugate drug substance and drug product. Their one-stop approach allows all services to be within a on...e-hour drive, allowing the company to provide an unprecedented streamlined platform that cuts in half the time it takes to develop and manufacture these complex modalities.
Service Offerings:
Bioconjugation Discovery
Formulation and DP Development
Payload and Linker R&D and Manufacturing
BioConjugation Process Development
GMP Mab Intermediate and Conjugation Manufacturing
